FIELD: medicine.
SUBSTANCE: invention relates to the use of physiologically active water-soluble tyrosine derivatives of general formula (I) for the preparation of a medicament having analgesic, anti-inflammatory and antiedemic action.
R1=H.
EFFECT: claimed derivatives can be used in creams, ointments or gels with a specified spectrum of activity.
1 cl, 1 dwg, 8 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
TYROSINE HETEROCYCLIC AMIDES, HAVING ANALGESIC, ANTI-INFLAMMATORY AND ANTIEDEMIC ACTION | 2018 |
|
RU2685505C1 |
PHARMACEUTICAL COMPOSITION IN GEL MEDICINAL FORM FOR LOCAL USE ON THE BASIS OF N-(2-ADAMANTIL)-HEXAMETHYLENEMINE HYDROCHLORIDE | 2017 |
|
RU2663452C1 |
NOVEL EFFICIENT INHIBITOR OF KINASE 4, ASSOCIATED WITH INTERLEUKIN-1 (IRAK4) | 2015 |
|
RU2613973C1 |
AGENT FOR TREATING INFLAMMATORY DISEASES OF THE JOINTS | 2019 |
|
RU2707278C1 |
5-ETHYL-2-AMINO-1,3,4-THIADIAZOLE DERIVATIVES WITH ANESTHETIC, ANTI-INFLAMMATORY, ANTI-ALLERGIC AND ANALGETIC ACTIVITY | 2016 |
|
RU2651572C2 |
ANALGESIC AND ANTI-INFLAMMATORY AGENT BASED ON 5-BUTYL-6-HYDROXY-2-METHYL PYRIMIDINE-4(3H)-ONE | 2015 |
|
RU2605265C1 |
ARTHRONOSOS CURE | 2007 |
|
RU2353349C2 |
ANTI-INFLAMMATORY PREPARATION BASED ON KETOPROFEN AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2694221C1 |
ANALGESIC AND ANTI-INFLAMMATORY AGENT WITH ANTIMICROBIAL ACTIVITY | 2019 |
|
RU2693475C1 |
AGENT POSSESSING ANTI-INFLAMMATORY ACTION | 2011 |
|
RU2483741C1 |
Authors
Dates
2019-01-30—Published
2017-10-27—Filed